FTAAX | MAMAX | FTAAX / MAMAX | |
Total Expense Ratio | 0.79 | 0.90 | 88% |
Annual Report Gross Expense Ratio | 0.79 | 0.90 | 88% |
Fund Existence | 18 years | 23 years | - |
Gain YTD | 2.680 | 4.082 | 66% |
Front Load | 6% | 6% | 100% |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 1.97B | 6.32B | 31% |
Annual Yield % from dividends | 2.69 | 2.42 | 111% |
Returns for 1 year | 7.02 | 4.40 | 160% |
Returns for 3 years | 11.61 | 10.74 | 108% |
Returns for 5 years | 18.27 | 22.86 | 80% |
Returns for 10 years | 32.01 | 38.79 | 83% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHSZX | 39.72 | 0.17 | +0.43% |
PGIM Jennison Health Sciences Z | |||
MSHNX | 13.98 | 0.01 | +0.07% |
Morgan Stanley Inst Permanence A | |||
IVITX | 22.21 | 0.01 | +0.05% |
VY® Invesco Growth and Income S2 | |||
FDETX | 25.27 | -0.01 | -0.04% |
Fidelity Advisor Capital Development O | |||
GHAYX | 40.08 | -0.07 | -0.17% |
VanEck Global Resources Fund Y |